Breast cancer treatment with Herceptin

According to World Health Organization data, as well as cancer register preliminary data of  9 months of 2015, in Georgia, the main cause of mortality caused by malignant newborns in women is malignant tumor of the breast. From 2016 the Ministry of  Health begins to provide medication with trastuzumab (Herceptin) for early breast aggressive HER-2 receptor diagnoses;